Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)
Clinical trial NCT01554176 · TERMINATED
Trial details
- NCT number
- NCT01554176
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-18
- Primary completion
- 2013-09-03
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.